Literature DB >> 10699451

Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke.

J Ren1, P L Kaplan, M F Charette, H Speller, S P Finklestein.   

Abstract

Osteogenic protein-1 (OP-1, BMP-7) is a member of the bone morphogenetic protein subfamily of the TGF-ss superfamily that selectively stimulates dendritic neuronal outgrowth. In previous studies, we found that the intracisternal injection of OP-1, starting at one day after stroke, enhanced sensorimotor recovery of the contralateral limbs following unilateral cerebral infarction in rats. In the current study, we further explored the time window during which intracisternal OP-1 enhances sensorimotor recovery, as assessed by limb placing tests. We found that intracisternal OP-1 (10 microg) given 1 and 3 days, or 3 and 5 days, but not 7 and 9 days after stroke, significantly enhanced recovery of forelimb and hindlimb placing. There was no difference in infarct volume between vehicle- and OP-1-treated animals. The mechanism of OP-1 action might be stimulation of new dendritic sprouting in the remaining uninjured brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699451     DOI: 10.1016/s0028-3908(99)00261-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  22 in total

Review 1.  Biomarkers and predictors of restorative therapy effects after stroke.

Authors:  Erin Burke; Steven C Cramer
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

Review 2.  Imaging motor recovery after stroke.

Authors:  Nuray Yozbatiran; Steven C Cramer
Journal:  NeuroRx       Date:  2006-10

3.  Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke.

Authors:  Quynh Vu; Kate Xie; Mark Eckert; Weian Zhao; Steven C Cramer
Journal:  Neurology       Date:  2014-03-07       Impact factor: 9.910

4.  Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.

Authors:  Mikko Airavaara; Matt J Chiocco; Doug B Howard; Katie L Zuchowski; Johan Peränen; Chao Liu; Shengyun Fang; Barry J Hoffer; Yun Wang; Brandon K Harvey
Journal:  Exp Neurol       Date:  2010-06-02       Impact factor: 5.330

Review 5.  Molecular, cellular and functional events in axonal sprouting after stroke.

Authors:  S Thomas Carmichael; Balachandar Kathirvelu; Catherine A Schweppe; Esther H Nie
Journal:  Exp Neurol       Date:  2016-02-10       Impact factor: 5.330

6.  Different temporal patterns in the expressions of bone morphogenetic proteins and noggin during astroglial scar formation after ischemic stroke.

Authors:  Jin A Shin; Jihee Lee Kang; Kyung-Eun Lee; Eun-Mi Park
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

7.  Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis.

Authors:  Leslie Crews; Anthony Adame; Christina Patrick; Alexandra Delaney; Emiley Pham; Edward Rockenstein; Lawrence Hansen; Eliezer Masliah
Journal:  J Neurosci       Date:  2010-09-15       Impact factor: 6.167

Review 8.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

9.  Reproducible and persistent weakness in adult rats after surgical resection of motor cortex: evaluation with limb placement test.

Authors:  Do-Hun Lee; Seok Ho Hong; Seung-Ki Kim; Chang-Sub Lee; Ji Hoon Phi; Byung-Kyu Cho; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2009-08-22       Impact factor: 1.475

10.  Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in rats.

Authors:  Mikko Airavaara; Hui Shen; Chi-Chung Kuo; Johan Peränen; Mart Saarma; Barry Hoffer; Yun Wang
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.